Clinical features and hearing prognosis of idiopathic sudden sensorineural hearing loss in patients undergoing hemodialysis: A retrospective study

Kengo Yamamoto; Takaomi Kurioka; Shogo Furuki; Hajime Sano; Kentaro Ohashi; Motofumi Ohki; Taku Yamashita

doi:10.1002/lio2.630

Laryngoscope Investigative Otolaryngology (Oct 2021)

Clinical features and hearing prognosis of idiopathic sudden sensorineural hearing loss in patients undergoing hemodialysis: A retrospective study

Kengo Yamamoto,
Takaomi Kurioka,
Shogo Furuki,
Hajime Sano,
Kentaro Ohashi,
Motofumi Ohki,
Taku Yamashita

Affiliations

Kengo Yamamoto: Department of Otorhinolaryngology Head and Neck Surgery Kitasato University School of Medicine Sagamihara‐shi Kanagawa Japan
Takaomi Kurioka: Department of Otorhinolaryngology Head and Neck Surgery Kitasato University School of Medicine Sagamihara‐shi Kanagawa Japan
Shogo Furuki: Department of Otorhinolaryngology Head and Neck Surgery Kitasato University School of Medicine Sagamihara‐shi Kanagawa Japan
Hajime Sano: School of Allied Health Science Kitasato University Sagamihara‐shi Kanagawa Japan
Kentaro Ohashi: Department of Otorhinolaryngology Kitasato University Medical Center Saitama Japan
Motofumi Ohki: Department of Otorhinolaryngology Kitasato University Medical Center Saitama Japan
Taku Yamashita: Department of Otorhinolaryngology Head and Neck Surgery Kitasato University School of Medicine Sagamihara‐shi Kanagawa Japan

DOI: https://doi.org/10.1002/lio2.630
Journal volume & issue: Vol. 6, no. 5
pp. 1104 – 1109

Abstract

Read online

Abstract Background Patients undergoing hemodialysis (HD) tend to experience hearing loss, including idiopathic sudden sensorineural hearing loss (ISSHL). However, little is known about the relationship between HD and ISSHL. Objective To investigate the effects of HD on the hearing level and the treatment prognosis of ISSHL. Methods We reviewed the medical records of 23 patients with ISSHL receiving HD treatment (HD group) and 101 patients with ISSHL not receiving HD treatment (non‐HD group), and assessed clinical features, results of audiometric tests and blood examination results. Results Statistically significant differences were not observed in pretreatment hearing level and hearing recovery of the ear affected with ISSHL between the two groups (P > .05). Conversely, hearing thresholds in the unaffected ear were statistically different (P < .0001), and the hearing thresholds of the HD groups were significantly increased compared with those of the non‐HD groups, especially at high frequency. In addition, patients with renal dysfunction not receiving HD treatment showed similar hearing thresholds in the unaffected ear when compared with patients receiving HD treatment. Conclusion HD itself did not influence the treatment prognosis of ISSHL. Renal dysfunction itself, and not HD treatment, worsened the hearing level. As similar treatment results are expected, standard treatment should be administered to patients undergoing HD. Level of Evidence 3b.

Published in Laryngoscope Investigative Otolaryngology

ISSN: 2378-8038 (Online)
Publisher: Wiley
Country of publisher: United States
LCC subjects: Medicine: Otorhinolaryngology; Medicine: Surgery
Website: https://onlinelibrary.wiley.com/journal/23788038

About the journal

Abstract

Keywords